Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TF0023 Spray for Functional Improvement in Ischemic Stroke
NCT02785120Phase 2Suspended
- Sponsor
- Techfields Inc.
- Start
- Mar 2017
- Primary completion
- Oct 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of 2-(diethylamino)ethyl 2-acetyloxybenzoate hydrochloride in ischemic stroke, sponsored by Techfields Inc.. Started Mar 2017; status: suspended.
02
Drugs
2-(diethylamino)ethyl 2-acetyloxybenzoate hydrochloride
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT02785120.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02785120.